BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 net loss of $29.5M. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.57 million.

GUIDANCE:

BioNano Genomics, Inc. sees FY2022 revenue of $24-27 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.